electroCore, Inc.NASDAQ:ECOR
- LAST PRICE5.7600
- TODAY'S CHANGE (%)0.1100 (1.9469%)
- Bid / Lots5.3200/ 5
- Ask / Lots7.2800/ 1
- Open / Previous Close5.6500 / 5.6500
- Day Range
- 52 Week Range
- Volume17,008
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ECOR |
|---|---|---|
| 09:32 ET | 1098 | 5.7171 |
| 10:06 ET | 1300 | 5.72 |
| 10:10 ET | 3172 | 5.65 |
| 11:13 ET | 500 | 5.65 |
| 11:15 ET | 3658 | 5.69 |
| 11:18 ET | 1100 | 5.85 |
| 11:22 ET | 916 | 5.7 |
| 11:36 ET | 200 | 5.6248 |
| 02:40 ET | 274 | 6.0171 |
| 03:36 ET | 664 | 5.9008 |
| 03:59 ET | 275 | 5.76 |
Apr 8, 2024
electroCore Announces the Launch of Truvaga Plus(R) for General Wellness, from 8:30AM ET on Monday Apr 08, 2024 by Dow Jones
8:30AM ET on Monday Apr 08, 2024 by Dow Jones
Apr 2, 2024
electroCore Expands Intellectual Property Portfolio, from 8:00AM ET on Tuesday Apr 02, 2024 by Dow Jones
8:00AM ET on Tuesday Apr 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
electroCore, Inc. | 33.9M | -1.6x | --- |
Precision Optics Corporation Inc | 34.4M | -19.4x | --- |
ReWalk Robotics Ltd | 40.1M | -1.8x | --- |
DarioHealth Corp | 43.3M | -0.7x | --- |
DermTech Inc | 20.3M | -0.2x | --- |
Lucid Diagnostics Inc | 32.3M | -0.5x | --- |
Company Information
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.
Contact Information
- Headquarters
- 200 FORGE WAY, SUITE 205ROCKAWAY, NJ, United States 07866
- Phone
- 973-290-0097
- Fax
- 973-290-9171
Executives
- Independent Non-Executive Chairman of the Board
- F. Peter Cuneo
- Chief Executive Officer, Director
- Daniel Goldberger
- Chief Financial Officer
- Brian Posner
- Director
- Charles Theofilos
- Independent Director
- Thomas Errico
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $33.9M |
|---|---|
Revenue (TTM) | $16.0M |
Shares Outstanding | 6.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.94 |
EPS | $-3.56 |
Book Value | $1.24 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | 2.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -120.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
